-
1
-
-
0033536024
-
Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis
-
Wittrup HH, Tybjaerg-Hansen A, Nordestgaard BG Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis. Circulation 1999, 99:2901.
-
(1999)
Circulation
, vol.99
, pp. 2901
-
-
Wittrup, H.H.1
Tybjaerg-Hansen, A.2
Nordestgaard, B.G.3
-
2
-
-
0030464749
-
Higher triglycerides, lower high-density lipoprotein cholesterol, and higher systolic blood pressure in lipoprotein lipase-deficient heterozygotes
-
Sprecher DL, Harris BV, Stein EA, et al. Higher triglycerides, lower high-density lipoprotein cholesterol, and higher systolic blood pressure in lipoprotein lipase-deficient heterozygotes. Circulation 1996, 94:3239.
-
(1996)
Circulation
, vol.94
, pp. 3239
-
-
Sprecher, D.L.1
Harris, B.V.2
Stein, E.A.3
-
3
-
-
0027317255
-
Hypertriglyceridaemia and vascular risk. Report of a meeting of physicians and scientists, University College London Medical School
-
Hypertriglyceridaemia and vascular risk. Report of a meeting of physicians and scientists, University College London Medical School. Lancet 1993, 342:781.
-
(1993)
Lancet
, vol.342
, pp. 781
-
-
-
4
-
-
0018649439
-
Atherogenesis: A postprandial phenomenon
-
Zilversmit DB Atherogenesis: a postprandial phenomenon. Circulation 1979, 60:473.
-
(1979)
Circulation
, vol.60
, pp. 473
-
-
Zilversmit, D.B.1
-
5
-
-
0035893334
-
Comparison of remnant-like lipoprotein particles in postmenopausal women with and without coronary artery disease and in men with coronary artery disease
-
Fukushima H, Kugiyama K, Sugiyama S, et al. Comparison of remnant-like lipoprotein particles in postmenopausal women with and without coronary artery disease and in men with coronary artery disease. Am J Cardiol 2001, 88:1370.
-
(2001)
Am J Cardiol
, vol.88
, pp. 1370
-
-
Fukushima, H.1
Kugiyama, K.2
Sugiyama, S.3
-
6
-
-
0026021161
-
Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease
-
DeFronzo RA, Ferrannini E Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991, 14:173.
-
(1991)
Diabetes Care
, vol.14
, pp. 173
-
-
DeFronzo, R.A.1
Ferrannini, E.2
-
7
-
-
0642272544
-
Use of metabolic markers to identify overweight individuals who are insulin resistant
-
McLaughlin T, Abbasi F, Cheal K, et al. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 2003, 139:802.
-
(2003)
Ann Intern Med
, vol.139
, pp. 802
-
-
McLaughlin, T.1
Abbasi, F.2
Cheal, K.3
-
8
-
-
63849198178
-
Hypertriglyceridemia and its pharmacologic treatment among US adults
-
Ford ES, Li C, Zhao G, et al. Hypertriglyceridemia and its pharmacologic treatment among US adults. Arch Intern Med 2009, 169:572.
-
(2009)
Arch Intern Med
, vol.169
, pp. 572
-
-
Ford, E.S.1
Li, C.2
Zhao, G.3
-
9
-
-
0002746856
-
Serum triglycerides in coronary artery disease
-
Albrink M, Man E Serum triglycerides in coronary artery disease. AMA Arch Intern Med 1959, 103:4.
-
(1959)
AMA Arch Intern Med
, vol.103
, pp. 4
-
-
Albrink, M.1
Man, E.2
-
10
-
-
0029884921
-
Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle aged men
-
Assmann G, Schulte H, Eckardstein AV Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle aged men. Am J Cardiol 1996, 77:1179.
-
(1996)
Am J Cardiol
, vol.77
, pp. 1179
-
-
Assmann, G.1
Schulte, H.2
Eckardstein, A.V.3
-
11
-
-
0037154285
-
Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Munster (PROCAM) study
-
Assmann G, Cullen P, Schulte H Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Munster (PROCAM) study. Circulation 2002, 105:310.
-
(2002)
Circulation
, vol.105
, pp. 310
-
-
Assmann, G.1
Cullen, P.2
Schulte, H.3
-
12
-
-
0026100848
-
Twelve-year incidence of coronary heart disease in middle-aged adults during the era of hypertensive therapy: The Framingham offspring study
-
Wilson PW, Anderson KM, Castelli WP Twelve-year incidence of coronary heart disease in middle-aged adults during the era of hypertensive therapy: the Framingham offspring study. Am J Med 1991, 90:11.
-
(1991)
Am J Med
, vol.90
, pp. 11
-
-
Wilson, P.W.1
Anderson, K.M.2
Castelli, W.P.3
-
13
-
-
0035177104
-
Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: Results from the Framingham Heart Study
-
McNamara JR, Shah PK, Nakajima K, et al. Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study. Atherosclerosis 2001, 154:229.
-
(2001)
Atherosclerosis
, vol.154
, pp. 229
-
-
McNamara, J.R.1
Shah, P.K.2
Nakajima, K.3
-
14
-
-
0029838433
-
Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: A meta-analysis of population-based prospective studies
-
Hokanson JE, Austin MA Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996, 3:213-219.
-
(1996)
J Cardiovasc Risk
, vol.3
, pp. 213-219
-
-
Hokanson, J.E.1
Austin, M.A.2
-
15
-
-
0032080923
-
Normal triglyceride levels and coronary artery disease events. The Baltimore Coronary Observational Long-Term Study
-
Miller M, Seidler A, Moalemi A, Pearson TA Normal triglyceride levels and coronary artery disease events. The Baltimore Coronary Observational Long-Term Study. J Am Coll Cardiol 1998, 31:1252.
-
(1998)
J Am Coll Cardiol
, vol.31
, pp. 1252
-
-
Miller, M.1
Seidler, A.2
Moalemi, A.3
Pearson, T.A.4
-
16
-
-
0032562257
-
Triglyceride concentration and ischemic heart disease: An eight year follow up in the Copenhagen Male Study
-
Jeppesen J, Hein HO, Suadicani P, Gyntelberg F Triglyceride concentration and ischemic heart disease: an eight year follow up in the Copenhagen Male Study. Circulation 1998, 97:1029.
-
(1998)
Circulation
, vol.97
, pp. 1029
-
-
Jeppesen, J.1
Hein, H.O.2
Suadicani, P.3
Gyntelberg, F.4
-
17
-
-
0035847610
-
Low triglycerides-high high-density lipoprotein cholesterol and risk of ischemic heart disease
-
Jeppesen J, Hein HO, Suadicani P, Gyntelberg F Low triglycerides-high high-density lipoprotein cholesterol and risk of ischemic heart disease. Arch Intern Med 2001, 161:361.
-
(2001)
Arch Intern Med
, vol.161
, pp. 361
-
-
Jeppesen, J.1
Hein, H.O.2
Suadicani, P.3
Gyntelberg, F.4
-
18
-
-
7544226531
-
Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region
-
Patel A, Barzi F, Jamrozik K, et al. Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region. Circulation 2004, 110:2678.
-
(2004)
Circulation
, vol.110
, pp. 2678
-
-
Patel, A.1
Barzi, F.2
Jamrozik, K.3
-
19
-
-
33846637379
-
Triglycerides and the risk of coronary heart disease. 10,158 incident cases among 262,525 participants in 29 Western prospective studies
-
Sarwar N, Danesh J, Eiriksdottir G, et al. Triglycerides and the risk of coronary heart disease. 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation 2006, 115:450.
-
(2006)
Circulation
, vol.115
, pp. 450
-
-
Sarwar, N.1
Danesh, J.2
Eiriksdottir, G.3
-
20
-
-
68449103045
-
Triglycerides and coronary heart disease: Have recent insights yielded conclusive answers?
-
Sarwar N, Sattar N Triglycerides and coronary heart disease: have recent insights yielded conclusive answers?. Curr Opin Lipidol 2009, 20:275.
-
(2009)
Curr Opin Lipidol
, vol.20
, pp. 275
-
-
Sarwar, N.1
Sattar, N.2
-
21
-
-
34548798025
-
Changes in triglyceride levels and risk for coronary heart disease in young men
-
Tirosh A, Rudich A, Shochat T, et al. Changes in triglyceride levels and risk for coronary heart disease in young men. Ann Intern Med 2007, 147:377.
-
(2007)
Ann Intern Med
, vol.147
, pp. 377
-
-
Tirosh, A.1
Rudich, A.2
Shochat, T.3
-
22
-
-
68049114763
-
Steering Committees of IDEAL and TNT Trials: Plasma triglycerides and cardiovascular events in the Treating to New Targets and Incremental Decrease in End-Points through Aggressive Lipid Lowering trials of statins in patients with coronary artery disease
-
Faergeman O, Holme I, Fayyad R, et al. Steering Committees of IDEAL and TNT Trials: Plasma triglycerides and cardiovascular events in the Treating to New Targets and Incremental Decrease in End-Points through Aggressive Lipid Lowering trials of statins in patients with coronary artery disease. Am J Cardiol 2009, 104:459.
-
(2009)
Am J Cardiol
, vol.104
, pp. 459
-
-
Faergeman, O.1
Holme, I.2
Fayyad, R.3
-
23
-
-
38949171001
-
Impact of triglyceride levels beyond low-density cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial
-
Miller M, Cannon CP, Murphy SA, et al. Impact of triglyceride levels beyond low-density cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial. J Am Coll Cardiol 2008, 51:724.
-
(2008)
J Am Coll Cardiol
, vol.51
, pp. 724
-
-
Miller, M.1
Cannon, C.P.2
Murphy, S.A.3
-
24
-
-
0037109169
-
New perspectives on atherogenesis: Role of abnormal triglyceride-rich lipoprotein metabolism
-
Ginsberg HN New perspectives on atherogenesis: role of abnormal triglyceride-rich lipoprotein metabolism. Circulation 2002, 106:2137.
-
(2002)
Circulation
, vol.106
, pp. 2137
-
-
Ginsberg, H.N.1
-
25
-
-
0000795715
-
Introduction: Structure and metabolism of plasma lipoproteins
-
McGraw-Hill, New York, C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.)
-
Havel RJ, Kane JP Introduction: structure and metabolism of plasma lipoproteins. The metabolic and molecular bases of inherited disease 1995, 1841-1851. McGraw-Hill, New York. ed 7. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.).
-
(1995)
The metabolic and molecular bases of inherited disease
, pp. 1841-1851
-
-
Havel, R.J.1
Kane, J.P.2
-
26
-
-
40849145708
-
Lipid droplets in lipogenesis and lipolysis
-
Ducharme NA, Bickel PE Lipid droplets in lipogenesis and lipolysis. Endocrinology 2008, 149:942.
-
(2008)
Endocrinology
, vol.149
, pp. 942
-
-
Ducharme, N.A.1
Bickel, P.E.2
-
27
-
-
0025086368
-
Recent progress in understanding apolipoprotein B
-
Young SG Recent progress in understanding apolipoprotein B. Circulation 1990, 82:1574.
-
(1990)
Circulation
, vol.82
, pp. 1574
-
-
Young, S.G.1
-
28
-
-
0033826953
-
The role of the microsomal triglyceride transfer protein in abetalipoproteinemia
-
Berriot-Varoqueaux N, Aggerbeck LP, Samson-Bouma M, et al. The role of the microsomal triglyceride transfer protein in abetalipoproteinemia. Annu Rev Nutr 2000, 20:663.
-
(2000)
Annu Rev Nutr
, vol.20
, pp. 663
-
-
Berriot-Varoqueaux, N.1
Aggerbeck, L.P.2
Samson-Bouma, M.3
-
29
-
-
0033609775
-
Sterol regulatory element-binding protein negatively regulates microsomal triglyceride transfer protein gene transcription
-
Sato R, Miyamoto W, Inoue J, et al. Sterol regulatory element-binding protein negatively regulates microsomal triglyceride transfer protein gene transcription. J Biol Chem 1999, 274:24714.
-
(1999)
J Biol Chem
, vol.274
, pp. 24714
-
-
Sato, R.1
Miyamoto, W.2
Inoue, J.3
-
30
-
-
0023238065
-
Isolation and characterization of four heparin-binding cyanogen bromide peptides of human plasma apolipoprotein B
-
Hirose N, Blankenship DT, Krivanek MA, et al. Isolation and characterization of four heparin-binding cyanogen bromide peptides of human plasma apolipoprotein B. Biochemistry 1987, 26:5505.
-
(1987)
Biochemistry
, vol.26
, pp. 5505
-
-
Hirose, N.1
Blankenship, D.T.2
Krivanek, M.A.3
-
31
-
-
0023214927
-
Human apolipoprotein B-100 heparin-binding sites
-
Weisgraber KH, Rall SC Human apolipoprotein B-100 heparin-binding sites. J Biol Chem 1987, 262:11097.
-
(1987)
J Biol Chem
, vol.262
, pp. 11097
-
-
Weisgraber, K.H.1
Rall, S.C.2
-
32
-
-
0025835486
-
Lipolysis exposes unreactive endogenous apolipoprotein E-3 in human and rat plasma very low density lipoprotein
-
Sehayek E, Lewin-Velvert U, Chajek-Shaul T, Eisenberg S Lipolysis exposes unreactive endogenous apolipoprotein E-3 in human and rat plasma very low density lipoprotein. J Clin Invest 1991, 88:553.
-
(1991)
J Clin Invest
, vol.88
, pp. 553
-
-
Sehayek, E.1
Lewin-Velvert, U.2
Chajek-Shaul, T.3
Eisenberg, S.4
-
33
-
-
33947573537
-
Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons
-
Beigneux AP, Davies BS, Gin P, et al. Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons. Cell Metab 2007, 5:279.
-
(2007)
Cell Metab
, vol.5
, pp. 279
-
-
Beigneux, A.P.1
Davies, B.S.2
Gin, P.3
-
34
-
-
0040177065
-
Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins
-
Kowal RC, Herz J, Goldstein JL, et al. Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins. Proc Natl Acad Sci U S A 1989, 86:5810.
-
(1989)
Proc Natl Acad Sci U S A
, vol.86
, pp. 5810
-
-
Kowal, R.C.1
Herz, J.2
Goldstein, J.L.3
-
35
-
-
0024299370
-
Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology
-
Mahley RW Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988, 240:622.
-
(1988)
Science
, vol.240
, pp. 622
-
-
Mahley, R.W.1
-
36
-
-
0025860313
-
Chylomicron and chylomicron remnant catabolism
-
Mahley RW, Hussain M Chylomicron and chylomicron remnant catabolism. Curr Opin Lipidol 1991, 2:170-176.
-
(1991)
Curr Opin Lipidol
, vol.2
, pp. 170-176
-
-
Mahley, R.W.1
Hussain, M.2
-
37
-
-
0032743737
-
Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia): Questions, quandaries, and paradoxes
-
Mahley RW, Huang Y, Rall SC Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia): questions, quandaries, and paradoxes. J Lipid Res 1999, 40:1933.
-
(1999)
J Lipid Res
, vol.40
, pp. 1933
-
-
Mahley, R.W.1
Huang, Y.2
Rall, S.C.3
-
39
-
-
0023617743
-
Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon
-
Chen SH, Habib G, Yang CY, et al. Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon. Science 1987, 238:363.
-
(1987)
Science
, vol.238
, pp. 363
-
-
Chen, S.H.1
Habib, G.2
Yang, C.Y.3
-
40
-
-
17744390348
-
Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters
-
Berge KE, Tian H, Graf GA, et al. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 2000, 290:1771.
-
(2000)
Science
, vol.290
, pp. 1771
-
-
Berge, K.E.1
Tian, H.2
Graf, G.A.3
-
41
-
-
0035158733
-
Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption
-
Lee MH, Lu K, Hazard S, et al. Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat Genet 2001, 27:79.
-
(2001)
Nat Genet
, vol.27
, pp. 79
-
-
Lee, M.H.1
Lu, K.2
Hazard, S.3
-
42
-
-
0034518420
-
The role of orphan nuclear receptors in the regulation of cholesterol homeostasis
-
Repa JJ, Mangelsdorf DJ The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annu Rev Cell Dev Biol 2000, 16:459.
-
(2000)
Annu Rev Cell Dev Biol
, vol.16
, pp. 459
-
-
Repa, J.J.1
Mangelsdorf, D.J.2
-
43
-
-
0024299370
-
Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology
-
Mahley RW Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988, 240:622.
-
(1988)
Science
, vol.240
, pp. 622
-
-
Mahley, R.W.1
-
44
-
-
0024449363
-
The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein
-
Beisiegel U, Weber G, Ihrke W, et al. The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein. Nature 1989, 341:162.
-
(1989)
Nature
, vol.341
, pp. 162
-
-
Beisiegel, U.1
Weber, G.2
Ihrke, W.3
-
45
-
-
0024212728
-
Hepatocytic lipoprotein receptors and intracellular lipoprotein catabolism
-
Havel RJ, Hamilton RL Hepatocytic lipoprotein receptors and intracellular lipoprotein catabolism. Hepatology 1988, 8:1689.
-
(1988)
Hepatology
, vol.8
, pp. 1689
-
-
Havel, R.J.1
Hamilton, R.L.2
-
46
-
-
0025786502
-
39-kDa protein modulates binding of ligands to low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor
-
Herz J, Goldstein DK, Strickland JL, et al. 39-kDa protein modulates binding of ligands to low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. J Biol Chem 1991, 266:21232.
-
(1991)
J Biol Chem
, vol.266
, pp. 21232
-
-
Herz, J.1
Goldstein, D.K.2
Strickland, J.L.3
-
47
-
-
0040177065
-
Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins
-
Kowal RC, Herz J, Goldstein JL, et al. Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins. Proc Natl Acad Sci U S A 1989, 86:5810.
-
(1989)
Proc Natl Acad Sci U S A
, vol.86
, pp. 5810
-
-
Kowal, R.C.1
Herz, J.2
Goldstein, J.L.3
-
49
-
-
0026032958
-
Tissue-specific regulation of lipoprotein lipase activity by insulin/glucose in normal-weight humans
-
Farese RV, Yost TJ, Eckel RH Tissue-specific regulation of lipoprotein lipase activity by insulin/glucose in normal-weight humans. Metabolism 1991, 40:214.
-
(1991)
Metabolism
, vol.40
, pp. 214
-
-
Farese, R.V.1
Yost, T.J.2
Eckel, R.H.3
-
50
-
-
0025977492
-
Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects
-
de Graaf J, Hak-Lemmers HL, Hectors MP, et al. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler Thromb 1991, 11:298.
-
(1991)
Arterioscler Thromb
, vol.11
, pp. 298
-
-
de Graaf, J.1
Hak-Lemmers, H.L.2
Hectors, M.P.3
-
51
-
-
0030947630
-
Cellular consequences of the association of apoB lipoproteins with proteoglycans. Potential contribution to atherogenesis
-
Hurt-Camejo E, Olsson U, Wiklund O, et al. Cellular consequences of the association of apoB lipoproteins with proteoglycans. Potential contribution to atherogenesis. Arterioscler Thromb Vasc Biol 1997, 17:1011.
-
(1997)
Arterioscler Thromb Vasc Biol
, vol.17
, pp. 1011
-
-
Hurt-Camejo, E.1
Olsson, U.2
Wiklund, O.3
-
52
-
-
0022549920
-
A receptor-mediated pathway for cholesterol homeostasis
-
Brown MS, Goldstein JL A receptor-mediated pathway for cholesterol homeostasis. Science 1986, 232:34.
-
(1986)
Science
, vol.232
, pp. 34
-
-
Brown, M.S.1
Goldstein, J.L.2
-
53
-
-
0032562276
-
Expression of LDL receptor, VLDL receptor, LDL receptor-related protein, and scavenger receptor in rabbit atherosclerotic lesions. Marked induction of scavenger receptor and VLDL receptor expression during lesion development
-
Hiltunen TP, Luoma JS, Nikkari T, et al. Expression of LDL receptor, VLDL receptor, LDL receptor-related protein, and scavenger receptor in rabbit atherosclerotic lesions. Marked induction of scavenger receptor and VLDL receptor expression during lesion development. Circulation 1998, 97:1079.
-
(1998)
Circulation
, vol.97
, pp. 1079
-
-
Hiltunen, T.P.1
Luoma, J.S.2
Nikkari, T.3
-
54
-
-
0024603895
-
Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity
-
Steinberg D, Parthasarathy S, Carew TE, et al. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989, 320:915.
-
(1989)
N Engl J Med
, vol.320
, pp. 915
-
-
Steinberg, D.1
Parthasarathy, S.2
Carew, T.E.3
-
55
-
-
0034051080
-
Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species
-
Podrez EA, Febbraio M, Sheibani N, et al. Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species. J Clin Invest 2000, 105:1095.
-
(2000)
J Clin Invest
, vol.105
, pp. 1095
-
-
Podrez, E.A.1
Febbraio, M.2
Sheibani, N.3
-
56
-
-
0034101821
-
Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice
-
Febbraio M, Podrez EA, Smith JD, et al. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J Clin Invest 2000, 105:1049.
-
(2000)
J Clin Invest
, vol.105
, pp. 1049
-
-
Febbraio, M.1
Podrez, E.A.2
Smith, J.D.3
-
57
-
-
0034833822
-
CD36: A class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism
-
Febbraio M, Hajjar DP, Silverstein RL CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest 2001, 108:785.
-
(2001)
J Clin Invest
, vol.108
, pp. 785
-
-
Febbraio, M.1
Hajjar, D.P.2
Silverstein, R.L.3
-
58
-
-
66049157360
-
A cellular basis for the potential atherogenicity of triglyceride-rich lipoproteins
-
Springer-Verlag, New York, S. Slagov, W.P. Newman, S.A. Schaffer (Eds.)
-
Gianturco SH, Bradley WA A cellular basis for the potential atherogenicity of triglyceride-rich lipoproteins. Pathobiology of the human atherosclerotic plaque 1990, Springer-Verlag, New York. S. Slagov, W.P. Newman, S.A. Schaffer (Eds.).
-
(1990)
Pathobiology of the human atherosclerotic plaque
-
-
Gianturco, S.H.1
Bradley, W.A.2
-
59
-
-
0036300774
-
Hypertriglyceridemia: A review beyond low-density lipoprotein
-
Rapp RJ Hypertriglyceridemia: a review beyond low-density lipoprotein. Cardiol Rev 2002, 10:163.
-
(2002)
Cardiol Rev
, vol.10
, pp. 163
-
-
Rapp, R.J.1
-
60
-
-
0028172766
-
Low-density lipoproteins of the post prandial state induce cellular cholesteryl ester accumulation in macrophages
-
Lechleitner M, Hoppichler F, Föger B, Patsch JR Low-density lipoproteins of the post prandial state induce cellular cholesteryl ester accumulation in macrophages. Arterioscler Thromb 1994, 14:1799.
-
(1994)
Arterioscler Thromb
, vol.14
, pp. 1799
-
-
Lechleitner, M.1
Hoppichler, F.2
Föger, B.3
Patsch, J.R.4
-
61
-
-
0032581015
-
Association of remnant lipoprotein levels with impairment of endothelium-dependent vasomotor function in human coronary arteries
-
Kugiyama K, Doi H, Motoyama T, et al. Association of remnant lipoprotein levels with impairment of endothelium-dependent vasomotor function in human coronary arteries. Circulation 1998, 97:2519.
-
(1998)
Circulation
, vol.97
, pp. 2519
-
-
Kugiyama, K.1
Doi, H.2
Motoyama, T.3
-
62
-
-
84939401342
-
Intermediate-density lipoproteins and progression of coronary artery disease in hypercholesterolaemic men
-
Krauss RM, Lindgren FT, Williams PT, et al. Intermediate-density lipoproteins and progression of coronary artery disease in hypercholesterolaemic men. Lancet 1987, 2:62.
-
(1987)
Lancet
, vol.2
, pp. 62
-
-
Krauss, R.M.1
Lindgren, F.T.2
Williams, P.T.3
-
63
-
-
0033535977
-
Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease
-
Kugiyama K, Dori H, Takazoe K, et al. Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease. Circulation 1999, 99:2858.
-
(1999)
Circulation
, vol.99
, pp. 2858
-
-
Kugiyama, K.1
Dori, H.2
Takazoe, K.3
-
64
-
-
0035893334
-
Comparison of remnant-like lipoprotein particles in postmenopausal women with and without coronary artery disease and in men with coronary artery disease
-
Fukushima H, Kugiyama K, Sugiyama S, et al. Comparison of remnant-like lipoprotein particles in postmenopausal women with and without coronary artery disease and in men with coronary artery disease. Am J Cardiol 2001, 88:1370.
-
(2001)
Am J Cardiol
, vol.88
, pp. 1370
-
-
Fukushima, H.1
Kugiyama, K.2
Sugiyama, S.3
-
65
-
-
0033971682
-
Association of remnant-like particle cholesterol with coronary artery disease in patients with normal total cholesterol levels
-
Masuoka H, Kamei S, Wagayama H, et al. Association of remnant-like particle cholesterol with coronary artery disease in patients with normal total cholesterol levels. Am Heart J 2000, 139:305.
-
(2000)
Am Heart J
, vol.139
, pp. 305
-
-
Masuoka, H.1
Kamei, S.2
Wagayama, H.3
-
66
-
-
0026012340
-
Lipoprotein lipase modulates net secretory output of apolipoprotein B in vitro
-
Williams KJ, Petrie KA, Broacia RW, Swenson TL Lipoprotein lipase modulates net secretory output of apolipoprotein B in vitro. J Clin Invest 1991, 88:1300.
-
(1991)
J Clin Invest
, vol.88
, pp. 1300
-
-
Williams, K.J.1
Petrie, K.A.2
Broacia, R.W.3
Swenson, T.L.4
-
67
-
-
0030935559
-
Intermediate-density lipoproteins and progression of carotid arterial wall intima-media thickness
-
Hodis HN, Mack WJ, Dunn M, et al. Intermediate-density lipoproteins and progression of carotid arterial wall intima-media thickness. Circulation 1997, 95:2022.
-
(1997)
Circulation
, vol.95
, pp. 2022
-
-
Hodis, H.N.1
Mack, W.J.2
Dunn, M.3
-
68
-
-
0029062620
-
Triglyceride-rich lipoproteins and the progression of coronary artery disease
-
Hodis HN, Mack WJ Triglyceride-rich lipoproteins and the progression of coronary artery disease. Curr Opin Lipidol 1995, 6:209.
-
(1995)
Curr Opin Lipidol
, vol.6
, pp. 209
-
-
Hodis, H.N.1
Mack, W.J.2
-
69
-
-
0029986159
-
Lipoprotein subclasses in the Monitored Atherosclerosis Regression Study (MARS). Treatment effects and relation to coronary angiographic progression
-
Mack WJ, Krauss RM, Hodis HN Lipoprotein subclasses in the Monitored Atherosclerosis Regression Study (MARS). Treatment effects and relation to coronary angiographic progression. Arterioscler Thromb Vasc Biol 1996, 16:697.
-
(1996)
Arterioscler Thromb Vasc Biol
, vol.16
, pp. 697
-
-
Mack, W.J.1
Krauss, R.M.2
Hodis, H.N.3
-
70
-
-
0017347490
-
HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study
-
Castelli WP, Doyle JT, Gordon T, et al. HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study. Circulation 1977, 55:767.
-
(1977)
Circulation
, vol.55
, pp. 767
-
-
Castelli, W.P.1
Doyle, J.T.2
Gordon, T.3
-
71
-
-
0017614773
-
The Tromsø Heart Study. High-density lipoprotein and coronary heart disease: A prospective case-control study
-
Miller NE, Thelle DS, Forde OH, Mjos OD The Tromsø Heart Study. High-density lipoprotein and coronary heart disease: a prospective case-control study. Lancet 1977, 1:965.
-
(1977)
Lancet
, vol.1
, pp. 965
-
-
Miller, N.E.1
Thelle, D.S.2
Forde, O.H.3
Mjos, O.D.4
-
72
-
-
0017384270
-
High-density lipoprotein as a protective factor against coronary heart disease: The Framingham Study
-
Gordon T, Castelli M, Hjortland MC, et al. High-density lipoprotein as a protective factor against coronary heart disease: the Framingham Study. Am J Med 1977, 62:707.
-
(1977)
Am J Med
, vol.62
, pp. 707
-
-
Gordon, T.1
Castelli, M.2
Hjortland, M.C.3
-
73
-
-
0025014653
-
High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: The follow-up study of the Lipid Research Clinics Prevalence Study
-
Jacobs DR, Mebane IL, Bangdiwala SI, et al. High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study. Am J Epidemiol 1990, 131:32.
-
(1990)
Am J Epidemiol
, vol.131
, pp. 32
-
-
Jacobs, D.R.1
Mebane, I.L.2
Bangdiwala, S.I.3
-
74
-
-
0001823385
-
The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years of follow-up in the Framingham Study
-
Stokes J, Kannel WB, Wolf PA, et al. The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years of follow-up in the Framingham Study. Circulation 1987, 75(pt 2):V65.
-
(1987)
Circulation
, vol.75
, pp. V65
-
-
Stokes, J.1
Kannel, W.B.2
Wolf, P.A.3
-
75
-
-
0030046797
-
Identification of scavenger receptor SR-BI as a high-density lipoprotein receptor
-
Acton S, Rigotti A, Landschulz KT, et al. Identification of scavenger receptor SR-BI as a high-density lipoprotein receptor. Science 1996, 271:518.
-
(1996)
Science
, vol.271
, pp. 518
-
-
Acton, S.1
Rigotti, A.2
Landschulz, K.T.3
-
76
-
-
0027275449
-
Plasma cholesteryl ester transfer protein
-
Tall AR Plasma cholesteryl ester transfer protein. J Lipid Res 1993, 34:1255.
-
(1993)
J Lipid Res
, vol.34
, pp. 1255
-
-
Tall, A.R.1
-
77
-
-
0030064666
-
A docking receptor for HDL cholesterol esters
-
Steinberg D A docking receptor for HDL cholesterol esters. Science 1996, 271:460.
-
(1996)
Science
, vol.271
, pp. 460
-
-
Steinberg, D.1
-
78
-
-
0033560938
-
Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men
-
Lamarche B, Uffelman KD, Carpentier A, et al. Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men. J Clin Invest 1999, 103:1191.
-
(1999)
J Clin Invest
, vol.103
, pp. 1191
-
-
Lamarche, B.1
Uffelman, K.D.2
Carpentier, A.3
-
79
-
-
0018272750
-
Plasma triglycerides in the regulation of HDL-cholesterol levels
-
Schaefer EJ, Levy RI, Anderson DW, et al. Plasma triglycerides in the regulation of HDL-cholesterol levels. Lancet 1978, 2:391.
-
(1978)
Lancet
, vol.2
, pp. 391
-
-
Schaefer, E.J.1
Levy, R.I.2
Anderson, D.W.3
-
80
-
-
0025993346
-
Discrete subspecies of human low density lipoprotein are heterogeneous in their interaction with cellular LDL receptor
-
Nigon F, Lesnik P, Rouis M, et al. Discrete subspecies of human low density lipoprotein are heterogeneous in their interaction with cellular LDL receptor. J Lipid Res 1991, 32:1741.
-
(1991)
J Lipid Res
, vol.32
, pp. 1741
-
-
Nigon, F.1
Lesnik, P.2
Rouis, M.3
-
81
-
-
4444281385
-
Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes
-
Welty FK, Lichtenstein AH, Barrett PHR, et al. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes. Arterioscler Thromb Vasc Biol 2004, 24:1703.
-
(2004)
Arterioscler Thromb Vasc Biol
, vol.24
, pp. 1703
-
-
Welty, F.K.1
Lichtenstein, A.H.2
Barrett, P.H.R.3
-
82
-
-
0030896983
-
A common substitution (Asn291Ser) in lipoprotein lipase is associated with increased risk of ischemic heart disease
-
Wittrup HH, Tybjaerg-Hansen A, Abildgaard S, et al. A common substitution (Asn291Ser) in lipoprotein lipase is associated with increased risk of ischemic heart disease. J Clin Invest 1997, 99:1606.
-
(1997)
J Clin Invest
, vol.99
, pp. 1606
-
-
Wittrup, H.H.1
Tybjaerg-Hansen, A.2
Abildgaard, S.3
-
83
-
-
0034705084
-
A common mutation in lipoprotein lipase confers a 2-fold increase in risk of ischemic cerebrovascular disease in women but not in men
-
Wittrup HH, Nordestgaard BG, Sillesen H, et al. A common mutation in lipoprotein lipase confers a 2-fold increase in risk of ischemic cerebrovascular disease in women but not in men. Circulation 2000, 101:2393.
-
(2000)
Circulation
, vol.101
, pp. 2393
-
-
Wittrup, H.H.1
Nordestgaard, B.G.2
Sillesen, H.3
-
84
-
-
43149083460
-
Apoprotein A-V: An important regulator of triglyceride metabolism
-
[Epub ahead of print.]
-
Kluger M, Heeren J, Merkel M Apoprotein A-V: an important regulator of triglyceride metabolism. J Inherit Met Dis 2008 Apr 14, [Epub ahead of print.].
-
(2008)
J Inherit Met Dis
-
-
Kluger, M.1
Heeren, J.2
Merkel, M.3
-
85
-
-
66349097499
-
The ins (cell) and outs (plasma) of apolipoprotein A-V
-
Forte TM, Shu X, Ryan RO The ins (cell) and outs (plasma) of apolipoprotein A-V. J Lipid Res 2009, 50(Suppl):S150.
-
(2009)
J Lipid Res
, vol.50
, pp. S150
-
-
Forte, T.M.1
Shu, X.2
Ryan, R.O.3
-
86
-
-
2642714137
-
Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Invsestigators
-
Tahvanainen E, Syvanne M, Frick MH, et al. Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Invsestigators. J Clin Invest 1998, 101:956.
-
(1998)
J Clin Invest
, vol.101
, pp. 956
-
-
Tahvanainen, E.1
Syvanne, M.2
Frick, M.H.3
-
87
-
-
0031774386
-
Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterol
-
Zambon A, Deeb SS, Hokanson JE, et al. Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterol. Arterioscler Thromb Vasc Biol 1998, 18:1723.
-
(1998)
Arterioscler Thromb Vasc Biol
, vol.18
, pp. 1723
-
-
Zambon, A.1
Deeb, S.S.2
Hokanson, J.E.3
-
88
-
-
0017724406
-
Primary type V hyperlipoproteinemia. A descriptive study in 32 families
-
Greenberg BH, Blackwelder WC, Levy RI Primary type V hyperlipoproteinemia. A descriptive study in 32 families. Ann Intern Med 1977, 87:526.
-
(1977)
Ann Intern Med
, vol.87
, pp. 526
-
-
Greenberg, B.H.1
Blackwelder, W.C.2
Levy, R.I.3
-
89
-
-
0019954607
-
Increased prevalence of apolipoprotein E4 in type V hyperlipoproteinemia
-
Ghiselli G, Schaefer EJ, Zech LA, et al. Increased prevalence of apolipoprotein E4 in type V hyperlipoproteinemia. J Clin Invest 1982, 70:474.
-
(1982)
J Clin Invest
, vol.70
, pp. 474
-
-
Ghiselli, G.1
Schaefer, E.J.2
Zech, L.A.3
-
91
-
-
0030848547
-
Heterozygous lipoprotein lipase deficiency. Frequency in the general population, effect on plasma lipid levels, and risk of ischemic heart disease
-
Nordestgaard BG, Abildgaard S, Wittrup HH, et al. Heterozygous lipoprotein lipase deficiency. Frequency in the general population, effect on plasma lipid levels, and risk of ischemic heart disease. Circulation 1997, 96:1737.
-
(1997)
Circulation
, vol.96
, pp. 1737
-
-
Nordestgaard, B.G.1
Abildgaard, S.2
Wittrup, H.H.3
-
92
-
-
0027953129
-
Severe hypertriglyceridemia and pancreatitis when estrogen replacement therapy is given to hypertriglyceridemic women
-
Glueck CJ, Lang J, Hamer T, Tracy T Severe hypertriglyceridemia and pancreatitis when estrogen replacement therapy is given to hypertriglyceridemic women. J Lab Clin Med 1994, 123:18.
-
(1994)
J Lab Clin Med
, vol.123
, pp. 18
-
-
Glueck, C.J.1
Lang, J.2
Hamer, T.3
Tracy, T.4
-
93
-
-
0026762806
-
Familial lipoprotein disorders in patients with premature coronary artery disease
-
Genest JJ, Martin-Munley SS, McNamara JR, et al. Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation 1992, 85:2025.
-
(1992)
Circulation
, vol.85
, pp. 2025
-
-
Genest, J.J.1
Martin-Munley, S.S.2
McNamara, J.R.3
-
94
-
-
0034691299
-
Cardiovascular disease mortality in familial forms of hypertriglyceridemia: A 20-year prospective study
-
Austin MA, McKnight B, Edwards KL, et al. Cardiovascular disease mortality in familial forms of hypertriglyceridemia: a 20-year prospective study. Circulation 2000, 101:2777.
-
(2000)
Circulation
, vol.101
, pp. 2777
-
-
Austin, M.A.1
McKnight, B.2
Edwards, K.L.3
-
95
-
-
0019506499
-
Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: Normolipemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia
-
Kissebah AH, Alfarsi S, Adams PW Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: normolipemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia. Metabolism 1981, 30:856.
-
(1981)
Metabolism
, vol.30
, pp. 856
-
-
Kissebah, A.H.1
Alfarsi, S.2
Adams, P.W.3
-
96
-
-
0018843763
-
Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia
-
Chait A, Albers JJ, Brunzell JD Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia. Eur J Clin Invest 1980, 10:17.
-
(1980)
Eur J Clin Invest
, vol.10
, pp. 17
-
-
Chait, A.1
Albers, J.J.2
Brunzell, J.D.3
-
98
-
-
0015796295
-
Hyperlipidemia in coronary heart disease: II. Genetic analysis in 176 families and delineation of a new inherited disorder, combined hyperlipidemia
-
Goldstein JL, Schrott HG, Hazzard WR, et al. Hyperlipidemia in coronary heart disease: II. Genetic analysis in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest 1973, 52:1544.
-
(1973)
J Clin Invest
, vol.52
, pp. 1544
-
-
Goldstein, J.L.1
Schrott, H.G.2
Hazzard, W.R.3
-
99
-
-
33645534022
-
Familial combined hyperlipidemia: Upstream transcription factor 1 and beyond
-
Lee JC, Lusis AJ, Pajukanta P Familial combined hyperlipidemia: upstream transcription factor 1 and beyond. Curr Opin Lipidol 2006, 17:101.
-
(2006)
Curr Opin Lipidol
, vol.17
, pp. 101
-
-
Lee, J.C.1
Lusis, A.J.2
Pajukanta, P.3
-
100
-
-
0035213101
-
Monogenic dyslipidemias: Window on determinants of plasma lipoproteins metabolism
-
Hegele RA Monogenic dyslipidemias: window on determinants of plasma lipoproteins metabolism. Am J Hum Genet 2001, 69:1161.
-
(2001)
Am J Hum Genet
, vol.69
, pp. 1161
-
-
Hegele, R.A.1
-
101
-
-
0024160877
-
Role of insulin resistance in human disease
-
Reaven GM Role of insulin resistance in human disease. Diabetes 1988, 37:1595.
-
(1988)
Diabetes
, vol.37
, pp. 1595
-
-
Reaven, G.M.1
-
102
-
-
0028579473
-
Syndrome X: 6 years later
-
Reaven GM Syndrome X: 6 years later. J Intern Med 1994, 736:13-22.
-
(1994)
J Intern Med
, vol.736
, pp. 13-22
-
-
Reaven, G.M.1
-
103
-
-
0033860359
-
Insulin resistance and cardiovascular disease
-
Ginsberg HN Insulin resistance and cardiovascular disease. J Clin Invest 2000, 106:453.
-
(2000)
J Clin Invest
, vol.106
, pp. 453
-
-
Ginsberg, H.N.1
-
104
-
-
0026762806
-
Familial lipoprotein disorders in patients with premature coronary artery disease
-
Genest JJ, Martin-Munley SS, McNamara JR, et al. Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation 1992, 85:2025.
-
(1992)
Circulation
, vol.85
, pp. 2025
-
-
Genest, J.J.1
Martin-Munley, S.S.2
McNamara, J.R.3
-
105
-
-
0026731011
-
Familial combined hyperlipidemia and abnormal lipoprotein lipase
-
Babirak SP, Brown BG, Brunzell JD Familial combined hyperlipidemia and abnormal lipoprotein lipase. Arterioscler Thromb 1992, 12:1176.
-
(1992)
Arterioscler Thromb
, vol.12
, pp. 1176
-
-
Babirak, S.P.1
Brown, B.G.2
Brunzell, J.D.3
-
106
-
-
0029045344
-
A mutation in the promoter of the lipoprotein lipase (LPL) gene in a patient with familial combined hyperlipidemia and low LPL activity
-
Yang WS, Nevin DN, Peng R, et al. A mutation in the promoter of the lipoprotein lipase (LPL) gene in a patient with familial combined hyperlipidemia and low LPL activity. Proc Natl Acad Sci U S A 1995, 92:4462.
-
(1995)
Proc Natl Acad Sci U S A
, vol.92
, pp. 4462
-
-
Yang, W.S.1
Nevin, D.N.2
Peng, R.3
-
107
-
-
0029784503
-
Novel mechanism for defective receptor binding of apolipoprotein E2 in type III hyperlipoproteinemia
-
Dong LM, Parkin S, Trakhanov SD, et al. Novel mechanism for defective receptor binding of apolipoprotein E2 in type III hyperlipoproteinemia. Nat Struct Biol 1996, 3:718.
-
(1996)
Nat Struct Biol
, vol.3
, pp. 718
-
-
Dong, L.M.1
Parkin, S.2
Trakhanov, S.D.3
-
108
-
-
0028245754
-
Apolipoprotein E in hyperlipidemia
-
Walden CC, Hegele RA Apolipoprotein E in hyperlipidemia. Ann Intern Med 1994, 120:1026.
-
(1994)
Ann Intern Med
, vol.120
, pp. 1026
-
-
Walden, C.C.1
Hegele, R.A.2
-
109
-
-
0028587215
-
Dietary ethanol is associated with reduced lipolysis of intestinally derived lipoproteins
-
Pownall HJ Dietary ethanol is associated with reduced lipolysis of intestinally derived lipoproteins. J Lipid Res 1994, 35:2105.
-
(1994)
J Lipid Res
, vol.35
, pp. 2105
-
-
Pownall, H.J.1
-
110
-
-
1942419301
-
Moderate alcohol intake and lower risk of heart disease: Meta analysis of effects on lipids and haemostatic factors
-
Rimm EB, Williams P, Fosher K, et al. Moderate alcohol intake and lower risk of heart disease: meta analysis of effects on lipids and haemostatic factors. BMJ 1999, 319:1523.
-
(1999)
BMJ
, vol.319
, pp. 1523
-
-
Rimm, E.B.1
Williams, P.2
Fosher, K.3
-
111
-
-
0037126526
-
Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
-
Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Circulation 2002, 106:3143.
-
(2002)
Circulation
, vol.106
, pp. 3143
-
-
-
113
-
-
0032567996
-
Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome
-
Grundy SM Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome. Am J Cardiol 1998, 81:18B.
-
(1998)
Am J Cardiol
, vol.81
, pp. 18B
-
-
Grundy, S.M.1
-
114
-
-
0037116641
-
Prevalence of the metabolic syndrome among US adults: Findings from the Third National Health and Nutrition Examination Survey
-
Ford ES, Giles WH, Dietz WH Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 2002, 287:356.
-
(2002)
JAMA
, vol.287
, pp. 356
-
-
Ford, E.S.1
Giles, W.H.2
Dietz, W.H.3
-
115
-
-
34447520136
-
Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women
-
Bansal S, Buring JE, Rifai N, et al. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 2007, 298:309.
-
(2007)
JAMA
, vol.298
, pp. 309
-
-
Bansal, S.1
Buring, J.E.2
Rifai, N.3
-
116
-
-
34447511196
-
Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women
-
Nordestgaard BG, Benn M, Schnohr P, Tybjærg-Hansen A Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 2007, 298:299.
-
(2007)
JAMA
, vol.298
, pp. 299
-
-
Nordestgaard, B.G.1
Benn, M.2
Schnohr, P.3
Tybjærg-Hansen, A.4
-
117
-
-
0015348189
-
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
-
Friedewald WT, Levy RI, Fredrickson DS Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499.
-
(1972)
Clin Chem
, vol.18
, pp. 499
-
-
Friedewald, W.T.1
Levy, R.I.2
Fredrickson, D.S.3
-
118
-
-
0025118667
-
Atherogenic lipoprotein phenotype: A proposed genetic marker for coronary heart disease risk
-
Austin MA, King MC, Vranizan KM, et al. Atherogenic lipoprotein phenotype: a proposed genetic marker for coronary heart disease risk. Circulation 1990, 82:495.
-
(1990)
Circulation
, vol.82
, pp. 495
-
-
Austin, M.A.1
King, M.C.2
Vranizan, K.M.3
-
119
-
-
0037291228
-
Effect of desirable fasting triglycerides on the postprandial response to dietary fat
-
Miller M, Zhan M, Georgopoulos A Effect of desirable fasting triglycerides on the postprandial response to dietary fat. J Investig Med 2003, 51:50.
-
(2003)
J Investig Med
, vol.51
, pp. 50
-
-
Miller, M.1
Zhan, M.2
Georgopoulos, A.3
-
120
-
-
33746218177
-
The apolipoprotein story
-
Sacks FM The apolipoprotein story. Atheroscler Suppl 2006, 7:23.
-
(2006)
Atheroscler Suppl
, vol.7
, pp. 23
-
-
Sacks, F.M.1
-
121
-
-
2942750058
-
Atherogenic lipoprotein particles in atherosclerosis
-
Carmena R, Duriez P, Fruchart JC Atherogenic lipoprotein particles in atherosclerosis. Circulation 2004, 109:III2.
-
(2004)
Circulation
, vol.109
, pp. III2
-
-
Carmena, R.1
Duriez, P.2
Fruchart, J.C.3
-
122
-
-
0031890581
-
Atherogenic, dense low-density lipoproteins-pathophysiology and new therapeutic approaches
-
Chapman M, Guerin M, Bruckert E Atherogenic, dense low-density lipoproteins-pathophysiology and new therapeutic approaches. Eur Heart J 1998, 19(Suppl):A24.
-
(1998)
Eur Heart J
, vol.19
, pp. A24
-
-
Chapman, M.1
Guerin, M.2
Bruckert, E.3
-
124
-
-
0031032723
-
Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men: Prospective results from the Quebec Cardiovascular Study
-
Lamarche B, Tchernof A, Moorjani S, et al. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men: prospective results from the Quebec Cardiovascular Study. Circulation 1997, 95:69.
-
(1997)
Circulation
, vol.95
, pp. 69
-
-
Lamarche, B.1
Tchernof, A.2
Moorjani, S.3
-
125
-
-
33645741889
-
Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial
-
Otvos JD, Collins D, Freedman DS, et al. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial. Circulation 2006, 113:1556.
-
(2006)
Circulation
, vol.113
, pp. 1556
-
-
Otvos, J.D.1
Collins, D.2
Freedman, D.S.3
-
126
-
-
0035955042
-
Low-density lipoprotein size, pravastatin treatment, and coronary events
-
Campos H, Moye L, Glasser S, et al. Low-density lipoprotein size, pravastatin treatment, and coronary events. JAMA 2001, 286:1468.
-
(2001)
JAMA
, vol.286
, pp. 1468
-
-
Campos, H.1
Moye, L.2
Glasser, S.3
-
127
-
-
0026458728
-
Change in LDL particle size is associated with change in plasma triglyceride concentration
-
McNamara JR, Jenner JL, Li Z, et al. Change in LDL particle size is associated with change in plasma triglyceride concentration. Arterioscler Thromb 1992, 12:1284.
-
(1992)
Arterioscler Thromb
, vol.12
, pp. 1284
-
-
McNamara, J.R.1
Jenner, J.L.2
Li, Z.3
-
128
-
-
0345620788
-
Hypertriglyceridemia: Changes in the plasma lipoproteins associated with an increased risk of cardiovascular disease
-
Brewer H Hypertriglyceridemia: changes in the plasma lipoproteins associated with an increased risk of cardiovascular disease. Am J Cardiol 1999, 83:3F.
-
(1999)
Am J Cardiol
, vol.83
, pp. 3F
-
-
Brewer, H.1
-
129
-
-
2942750058
-
Atherogenic lipoprotein particles in atherosclerosis
-
Carmena R, Duriez P, Fruchart JC Atherogenic lipoprotein particles in atherosclerosis. Circulation 2004, 109:III2.
-
(2004)
Circulation
, vol.109
, pp. III2
-
-
Carmena, R.1
Duriez, P.2
Fruchart, J.C.3
-
130
-
-
33747404526
-
Apolipoprotein CIII induces expression of vascular cell adhesion molecule-1 in vascular endothelial cells and increases adhesion of monocytic cells
-
Kawakami A, Aikawa M, Alcaide P, et al. Apolipoprotein CIII induces expression of vascular cell adhesion molecule-1 in vascular endothelial cells and increases adhesion of monocytic cells. Circulation 2006, 114:681.
-
(2006)
Circulation
, vol.114
, pp. 681
-
-
Kawakami, A.1
Aikawa, M.2
Alcaide, P.3
-
131
-
-
0034912018
-
Non-high-density lipoprotein cholesterol level as predictor of cardiovascular disease mortality
-
Cui Y, Blumenthal R, Flaws J, et al. Non-high-density lipoprotein cholesterol level as predictor of cardiovascular disease mortality. Arch Intern Med 2001, 161:1413.
-
(2001)
Arch Intern Med
, vol.161
, pp. 1413
-
-
Cui, Y.1
Blumenthal, R.2
Flaws, J.3
-
132
-
-
34547876797
-
Clinical utility of different lipid measures for prediction of coronary heart disease in men and women
-
Ingelsson E, Schaefer EJ, Contois JH, et al. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. JAMA 2007, 298:776.
-
(2007)
JAMA
, vol.298
, pp. 776
-
-
Ingelsson, E.1
Schaefer, E.J.2
Contois, J.H.3
-
133
-
-
0014210692
-
Fat transport in lipoproteins-an integrated approach to mechanisms and disorders
-
Fredrickson DS, Levy RI, Lees RS Fat transport in lipoproteins-an integrated approach to mechanisms and disorders. N Engl J Med 1967, 276:148.
-
(1967)
N Engl J Med
, vol.276
, pp. 148
-
-
Fredrickson, D.S.1
Levy, R.I.2
Lees, R.S.3
-
134
-
-
33645096052
-
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: Report of the thirty-person/ten-country panel
-
Barter PJ, Ballantyne CM, Carmena R, et al. Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel. J Intern Med 2006, 259:247.
-
(2006)
J Intern Med
, vol.259
, pp. 247
-
-
Barter, P.J.1
Ballantyne, C.M.2
Carmena, R.3
-
135
-
-
0345620788
-
Hypertriglyceridemia: Changes in the plasma lipoproteins associated with an increased risk of cardiovascular disease
-
Brewer H Hypertriglyceridemia: changes in the plasma lipoproteins associated with an increased risk of cardiovascular disease. Am J Cardiol 1999, 83:3F.
-
(1999)
Am J Cardiol
, vol.83
, pp. 3F
-
-
Brewer, H.1
-
136
-
-
0027717922
-
Variability in cholesterol content and physical properties of lipoproteins containing apolipoprotein B-100
-
Abate N, Vega GL, Grundy SM Variability in cholesterol content and physical properties of lipoproteins containing apolipoprotein B-100. Atherosclerosis 1993, 104:159.
-
(1993)
Atherosclerosis
, vol.104
, pp. 159
-
-
Abate, N.1
Vega, G.L.2
Grundy, S.M.3
-
137
-
-
33644873843
-
Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men
-
Pischon T, Girman CJ, Sacks FM, et al. Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men. Circulation 2005, 112:3375.
-
(2005)
Circulation
, vol.112
, pp. 3375
-
-
Pischon, T.1
Girman, C.J.2
Sacks, F.M.3
-
138
-
-
8144223376
-
Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: Potential implications for clinical guidelines
-
Shai I, Rimm EB, Hankinson SE, et al. Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines. Circulation 2004, 110:2824.
-
(2004)
Circulation
, vol.110
, pp. 2824
-
-
Shai, I.1
Rimm, E.B.2
Hankinson, S.E.3
-
139
-
-
0037069434
-
Non-high-density lipoprotein cholesterol levels predict five-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI)
-
Bittner V, Hardison R, Kelsey S, et al. Non-high-density lipoprotein cholesterol levels predict five-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 2002, 106:2537.
-
(2002)
Circulation
, vol.106
, pp. 2537
-
-
Bittner, V.1
Hardison, R.2
Kelsey, S.3
-
140
-
-
0037335782
-
Plasma lipid profile and incident ischemic stroke: The Atherosclerosis Risk in Communities (ARIC) study
-
Shahar E, Chambless LE, Rosamond WD, et al. Plasma lipid profile and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. Stroke 2003, 34:623.
-
(2003)
Stroke
, vol.34
, pp. 623
-
-
Shahar, E.1
Chambless, L.E.2
Rosamond, W.D.3
-
141
-
-
22244446183
-
Non-HDL cholesterol, AJC apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women
-
Ridker P, Rifai N, Cook N, et al. Non-HDL cholesterol, AJC apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA 2005, 294:326.
-
(2005)
JAMA
, vol.294
, pp. 326
-
-
Ridker, P.1
Rifai, N.2
Cook, N.3
-
142
-
-
33750527116
-
Non-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease
-
Liu J, Sempos CT, Donahue RP, et al. Non-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease. Am J Cardiol 2006, 98:1363.
-
(2006)
Am J Cardiol
, vol.98
, pp. 1363
-
-
Liu, J.1
Sempos, C.T.2
Donahue, R.P.3
-
143
-
-
70450081001
-
Major lipids, apolipoproteins, and risk of vascular disease
-
Emerging Risk Factors Collaboration Major lipids, apolipoproteins, and risk of vascular disease. JAMA 2009, 302:1993.
-
(2009)
JAMA
, vol.302
, pp. 1993
-
-
-
144
-
-
0029741921
-
A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction
-
Stampfer MJ, Krauss RM, Ma J, et al. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA 1996, 276:882.
-
(1996)
JAMA
, vol.276
, pp. 882
-
-
Stampfer, M.J.1
Krauss, R.M.2
Ma, J.3
-
145
-
-
0032568082
-
Consensus statement: Role of therapy with "statins" in patients with hypertriglyceridemia
-
Grundy SM Consensus statement: role of therapy with "statins" in patients with hypertriglyceridemia. Am J Cardiol 1998, 81:B1.
-
(1998)
Am J Cardiol
, vol.81
, pp. B1
-
-
Grundy, S.M.1
-
147
-
-
49649118562
-
Acute pancreatitis in a cohort of 129 patients referred for severe hypertriglyceridemia
-
Lloret Linares C, Pelletier AL, Czernichow S, et al. Acute pancreatitis in a cohort of 129 patients referred for severe hypertriglyceridemia. Pancreas 2008, 37:13.
-
(2008)
Pancreas
, vol.37
, pp. 13
-
-
Lloret Linares, C.1
Pelletier, A.L.2
Czernichow, S.3
-
148
-
-
34548433987
-
Clinical practice. Hypertriglyceridemia
-
Brunzell JD Clinical practice. Hypertriglyceridemia. N Engl J Med 2007, 357:1009.
-
(2007)
N Engl J Med
, vol.357
, pp. 1009
-
-
Brunzell, J.D.1
-
149
-
-
40249120466
-
Standards of medical care in diabetes-2008
-
American Diabetes Association Standards of medical care in diabetes-2008. Diabetes Care 2008, 31:S12.
-
(2008)
Diabetes Care
, vol.31
, pp. S12
-
-
-
150
-
-
34248551882
-
Effects of a low-glycemic load vs low-fat diet in obese young adults: A randomized trial
-
Ebbeling CB, Leidig MM, Feldman HA, et al. Effects of a low-glycemic load vs low-fat diet in obese young adults: a randomized trial. JAMA 2007, 297:2092.
-
(2007)
JAMA
, vol.297
, pp. 2092
-
-
Ebbeling, C.B.1
Leidig, M.M.2
Feldman, H.A.3
-
151
-
-
0028235692
-
Mediterranean alpha-linolenic acid rich diet in secondary prevention of coronary heart disease
-
De Lorgeril M, Renaud S, Mamelle N, et al. Mediterranean alpha-linolenic acid rich diet in secondary prevention of coronary heart disease. Lancet 1994, 343:1454.
-
(1994)
Lancet
, vol.343
, pp. 1454
-
-
De Lorgeril, M.1
Renaud, S.2
Mamelle, N.3
-
152
-
-
0037161377
-
On the re-analysis of the GISSI-Prevenzione
-
Leaf A On the re-analysis of the GISSI-Prevenzione. Circulation 2002, 105:1874.
-
(2002)
Circulation
, vol.105
, pp. 1874
-
-
Leaf, A.1
-
153
-
-
29844444579
-
The effects of low-fat, high-carbohydrate diets on plasma lipoproteins, weight loss, and heart disease risk reduction
-
Schaefer EJ, Gleason JA, Dansinger ML The effects of low-fat, high-carbohydrate diets on plasma lipoproteins, weight loss, and heart disease risk reduction. Curr Atheroscler Rep 2005, 7:421.
-
(2005)
Curr Atheroscler Rep
, vol.7
, pp. 421
-
-
Schaefer, E.J.1
Gleason, J.A.2
Dansinger, M.L.3
-
155
-
-
23944490715
-
Diet, lifestyle, and nonstatin trials: Review of time to benefit
-
Denke MA Diet, lifestyle, and nonstatin trials: review of time to benefit. Am J Cardiol 2005, 96(Suppl):3F.
-
(2005)
Am J Cardiol
, vol.96
, pp. 3F
-
-
Denke, M.A.1
-
156
-
-
18044405166
-
Diets and cardiovascular disease: An evidence-based assessment
-
Parikh P, McDaniel MC, Ashen MD, et al. Diets and cardiovascular disease: an evidence-based assessment. J Am Coll Cardiol 2005, 45:1379.
-
(2005)
J Am Coll Cardiol
, vol.45
, pp. 1379
-
-
Parikh, P.1
McDaniel, M.C.2
Ashen, M.D.3
-
157
-
-
33745607390
-
Diet and lifestyle recommendations revision 2006: A scientific statement from the American Heart Association Nutrition Committee
-
Lichtenstein A, Appel LJ, Brands M, et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 2006, 114:82.
-
(2006)
Circulation
, vol.114
, pp. 82
-
-
Lichtenstein, A.1
Appel, L.J.2
Brands, M.3
-
158
-
-
0037203476
-
Randomized clinical trials on the effects of dietary fat and carbohydrate on plasma lipoproteins and cardiovascular disease
-
Sacks FM, Katan M Randomized clinical trials on the effects of dietary fat and carbohydrate on plasma lipoproteins and cardiovascular disease. Am J Med 2002, 113:13S.
-
(2002)
Am J Med
, vol.113
, pp. 13S
-
-
Sacks, F.M.1
Katan, M.2
-
159
-
-
33749065167
-
Summary of American Heart Association Diet and Lifestyle Recommendations revision 2006
-
Lichtenstein AH, Appel LJ, Brands M, et al. Summary of American Heart Association Diet and Lifestyle Recommendations revision 2006. Arterioscler Thromb Vasc Biol 2006, 26:2186.
-
(2006)
Arterioscler Thromb Vasc Biol
, vol.26
, pp. 2186
-
-
Lichtenstein, A.H.1
Appel, L.J.2
Brands, M.3
-
160
-
-
0026781014
-
Effects of weight reduction on blood lipids and lipoproteins: A meta-analysis
-
Dattilo AM, Kris-Etherton PM Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr 1992, 56:320.
-
(1992)
Am J Clin Nutr
, vol.56
, pp. 320
-
-
Dattilo, A.M.1
Kris-Etherton, P.M.2
-
161
-
-
0034454766
-
Effect of weight loss with reduction of intra-abdominal fat on lipid metabolism in older men
-
Purnell JQ, Kahn SE, Albers JJ, et al. Effect of weight loss with reduction of intra-abdominal fat on lipid metabolism in older men. J Clin Endocrinol Metab 2000, 85:977.
-
(2000)
J Clin Endocrinol Metab
, vol.85
, pp. 977
-
-
Purnell, J.Q.1
Kahn, S.E.2
Albers, J.J.3
-
162
-
-
34250783134
-
Effect of onsite dietitian counseling on weight loss and lipid levels in an outpatient physician office
-
Welty FK, Nasca MM, Lew NS, et al. Effect of onsite dietitian counseling on weight loss and lipid levels in an outpatient physician office. Am J Cardiol 2007, 100:73.
-
(2007)
Am J Cardiol
, vol.100
, pp. 73
-
-
Welty, F.K.1
Nasca, M.M.2
Lew, N.S.3
-
163
-
-
33751231439
-
Lifestyle intervention and coronary heart disease risk factor changes over 18 months in postmenopausal women: The Women On the Move through Activity and Nutrition (WOMAN study) clinical trial
-
Kuller LH, Kinzel LS, Pettee KK, et al. Lifestyle intervention and coronary heart disease risk factor changes over 18 months in postmenopausal women: the Women On the Move through Activity and Nutrition (WOMAN study) clinical trial. J Womens Health (Larchmt) 2006, 15:962.
-
(2006)
J Womens Health (Larchmt)
, vol.15
, pp. 962
-
-
Kuller, L.H.1
Kinzel, L.S.2
Pettee, K.K.3
-
164
-
-
0037094131
-
Effect of addition of exercise to therapeutic lifestyle changes diet in enabling women and men with coronary heart disease to reach Adult Treatment Panel III low-density lipoprotein cholesterol goal without lowering high-density lipoprotein cholesterol
-
Welty FK, Stuart E, O'Meara M, Huddleston J Effect of addition of exercise to therapeutic lifestyle changes diet in enabling women and men with coronary heart disease to reach Adult Treatment Panel III low-density lipoprotein cholesterol goal without lowering high-density lipoprotein cholesterol. Am J Cardiol 2002, 89:1201.
-
(2002)
Am J Cardiol
, vol.89
, pp. 1201
-
-
Welty, F.K.1
Stuart, E.2
O'Meara, M.3
Huddleston, J.4
-
165
-
-
34247113737
-
COURAGE Trial Research Group: Optimal medical therapy with or without PCI for stable coronary disease
-
Boden WE, O'Rourke RA, Teo KK, et al. COURAGE Trial Research Group: Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007, 356:1503.
-
(2007)
N Engl J Med
, vol.356
, pp. 1503
-
-
Boden, W.E.1
O'Rourke, R.A.2
Teo, K.K.3
-
166
-
-
34548222136
-
Physical activity and public health: Updated recommendation for adults from the American College of Sports Medicine and the American Heart Association
-
Haskell WL, Lee IM, Pate RR, et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation 2007, 116:1081.
-
(2007)
Circulation
, vol.116
, pp. 1081
-
-
Haskell, W.L.1
Lee, I.M.2
Pate, R.R.3
-
168
-
-
0037038239
-
Effects of the amount and intensity of exercise on plasma lipoproteins
-
Kraus WE, Houmard JA, Duscha BD, et al. Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med 2002, 347:1483.
-
(2002)
N Engl J Med
, vol.347
, pp. 1483
-
-
Kraus, W.E.1
Houmard, J.A.2
Duscha, B.D.3
-
169
-
-
1842475776
-
Walking, lipids, and lipoproteins: A meta-analysis of randomized controlled trials
-
Kelley GA, Kelley KS, Tran ZV Walking, lipids, and lipoproteins: a meta-analysis of randomized controlled trials. Prev Med 2004, 38:651.
-
(2004)
Prev Med
, vol.38
, pp. 651
-
-
Kelley, G.A.1
Kelley, K.S.2
Tran, Z.V.3
-
170
-
-
0029029684
-
Long-term effects of varying intensities and formats of physical activity on participation rates, fitness and lipoproteins in men and women age 50 to 65 years
-
King AC, Haskell WL, Young DR, et al. Long-term effects of varying intensities and formats of physical activity on participation rates, fitness and lipoproteins in men and women age 50 to 65 years. Circulation 1995, 91:2596.
-
(1995)
Circulation
, vol.91
, pp. 2596
-
-
King, A.C.1
Haskell, W.L.2
Young, D.R.3
-
171
-
-
17644421390
-
Effect of different antilipidemic agents and diets on mortality: A systematic review
-
Studer M, Briel M, Leimenstoll B, et al. Effect of different antilipidemic agents and diets on mortality: a systematic review. Arch Intern Med 2005, 165:725.
-
(2005)
Arch Intern Med
, vol.165
, pp. 725
-
-
Studer, M.1
Briel, M.2
Leimenstoll, B.3
-
173
-
-
0028915838
-
A common variant in the gene for lipoprotein lipase (Asp9 Asn). Functional implications and prevalence in normal and hyperlipidemic subjects
-
Mailly F, Tugrul Y, Reymer PW, et al. A common variant in the gene for lipoprotein lipase (Asp9 Asn). Functional implications and prevalence in normal and hyperlipidemic subjects. Arterioscler Thromb Vasc Biol 1995, 15:468.
-
(1995)
Arterioscler Thromb Vasc Biol
, vol.15
, pp. 468
-
-
Mailly, F.1
Tugrul, Y.2
Reymer, P.W.3
-
174
-
-
0030587872
-
REGRESS Study Group: The Asp9 Asn mutation in the lipoprotein lipase gene is associated with increased progression of coronary atherosclerosis
-
Jukema JW, van Boven AJ, Groenemeijer B, et al. REGRESS Study Group: The Asp9 Asn mutation in the lipoprotein lipase gene is associated with increased progression of coronary atherosclerosis. Circulation 1996, 94:1913.
-
(1996)
Circulation
, vol.94
, pp. 1913
-
-
Jukema, J.W.1
van Boven, A.J.2
Groenemeijer, B.3
-
175
-
-
0032506273
-
Mechanism of action of fibrates on lipid and lipoprotein metabolism
-
Staels B, Dallongeville J, Auwerx J, et al. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 1998, 98:2088.
-
(1998)
Circulation
, vol.98
, pp. 2088
-
-
Staels, B.1
Dallongeville, J.2
Auwerx, J.3
-
176
-
-
0029119082
-
Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor
-
Vu-Dac N, Schoonjans K, Kosykh V, et al. Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor. J Clin Invest 1995, 96:741.
-
(1995)
J Clin Invest
, vol.96
, pp. 741
-
-
Vu-Dac, N.1
Schoonjans, K.2
Kosykh, V.3
-
177
-
-
8944252340
-
Opposite regulation of human versus mouse apoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice
-
Berthou L, Duverger N, Emmanuel F, et al. Opposite regulation of human versus mouse apoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice. J Clin Invest 1996, 97:2408.
-
(1996)
J Clin Invest
, vol.97
, pp. 2408
-
-
Berthou, L.1
Duverger, N.2
Emmanuel, F.3
-
178
-
-
0029793860
-
Gemfibrozil stimulates apolipoprotein A-I synthesis and secretion by stabilization of mRNA transcripts in human hepatoblastoma cell line (Hep G2)
-
Jin F-Y, Kamanna VS, Chuang M-Y, et al. Gemfibrozil stimulates apolipoprotein A-I synthesis and secretion by stabilization of mRNA transcripts in human hepatoblastoma cell line (Hep G2). Arterioscler Thromb Vasc Biol 1996, 16:1052.
-
(1996)
Arterioscler Thromb Vasc Biol
, vol.16
, pp. 1052
-
-
Jin, F.-Y.1
Kamanna, V.S.2
Chuang, M.-Y.3
-
179
-
-
34547687824
-
Fenofibrate therapy ameliorates fasting and postprandial lipoproteinemia, oxidative stress, and the inflammatory response in subjects with hypertriglyceridemia and the metabolic syndrome
-
Rosenson RS, Wolff DA, Huskin AL, et al. Fenofibrate therapy ameliorates fasting and postprandial lipoproteinemia, oxidative stress, and the inflammatory response in subjects with hypertriglyceridemia and the metabolic syndrome. Diabetes Care 2007, 30:1945.
-
(2007)
Diabetes Care
, vol.30
, pp. 1945
-
-
Rosenson, R.S.1
Wolff, D.A.2
Huskin, A.L.3
-
180
-
-
33846623798
-
Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets
-
Brown JD, Plutzky J Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets. Circulation 2007, 115:518.
-
(2007)
Circulation
, vol.115
, pp. 518
-
-
Brown, J.D.1
Plutzky, J.2
-
181
-
-
3142729178
-
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
-
Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004, 110:227.
-
(2004)
Circulation
, vol.110
, pp. 227
-
-
Grundy, S.M.1
Cleeman, J.I.2
Merz, C.N.3
-
182
-
-
0033520018
-
BIP Study Group: Elevated serum triglyceride levels and long-term mortality in patients with coronary heart disease: The Bezafibrate Infarction Prevention (BIP) registry
-
Haim M, Benderly M, Brunner D, et al. BIP Study Group: Elevated serum triglyceride levels and long-term mortality in patients with coronary heart disease: the Bezafibrate Infarction Prevention (BIP) registry. Circulation 1999, 100:475.
-
(1999)
Circulation
, vol.100
, pp. 475
-
-
Haim, M.1
Benderly, M.2
Brunner, D.3
-
183
-
-
0034604225
-
Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary heart disease: The Bezafibrate Infarction Prevention (BIP) study
-
Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary heart disease: the Bezafibrate Infarction Prevention (BIP) study. Circulation 2000, 102:21.
-
(2000)
Circulation
, vol.102
, pp. 21
-
-
-
184
-
-
0023232216
-
Helsinki Heart Study: Primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia: Safety of treatment, changes in risk factors, and incidence of coronary heart disease
-
Frick MH, Elo O, Haapa K, et al. Helsinki Heart Study: Primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia: safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 1987, 317:1237.
-
(1987)
N Engl J Med
, vol.317
, pp. 1237
-
-
Frick, M.H.1
Elo, O.2
Haapa, K.3
-
185
-
-
0026597808
-
Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in Helsinki Heart Study. Implications for treatment
-
Manninen V, Tenkanen L, Koskinen P, et al. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in Helsinki Heart Study. Implications for treatment. Circulation 1992, 85:37.
-
(1992)
Circulation
, vol.85
, pp. 37
-
-
Manninen, V.1
Tenkanen, L.2
Koskinen, P.3
-
186
-
-
0033527030
-
Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group: Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol
-
Rubins HB, Robins SJ, Collins D, et al. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group: Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. N Engl J Med 1999, 341:410.
-
(1999)
N Engl J Med
, vol.341
, pp. 410
-
-
Rubins, H.B.1
Robins, S.J.2
Collins, D.3
-
187
-
-
0035941990
-
Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: The Diabetes Atherosclerosis Intervention Study, a randomised study
-
Diabetes Atherosclerosis Intervention Study Investigators Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study. Lancet 2001, 357:905.
-
(2001)
Lancet
, vol.357
, pp. 905
-
-
-
188
-
-
28044452217
-
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): Randomised controlled trial
-
Keech A, Simes RJ, Barter P, et al. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 2005, 366:1849.
-
(2005)
Lancet
, vol.366
, pp. 1849
-
-
Keech, A.1
Simes, R.J.2
Barter, P.3
-
189
-
-
64749095070
-
Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study Investigators: Effects of fenofibrate treatment on cardiovascular disease risk in 9,795 individuals with type 2 diabetes and various components of the metabolic syndrome
-
Scott R, O'Brien R, Fulcher G, et al. Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study Investigators: Effects of fenofibrate treatment on cardiovascular disease risk in 9,795 individuals with type 2 diabetes and various components of the metabolic syndrome. Diabetes Care 2009, 32:493.
-
(2009)
Diabetes Care
, vol.32
, pp. 493
-
-
Scott, R.1
O'Brien, R.2
Fulcher, G.3
-
190
-
-
35548955508
-
The role of fibrates in the prevention of cardiovascular disease: A pooled meta-analysis of longterm randomized placebo-controlled trials
-
Saha SA, Kizhakepunnur LG, Bahekar A, Arora RR The role of fibrates in the prevention of cardiovascular disease: a pooled meta-analysis of longterm randomized placebo-controlled trials. Am Heart J 2007, 154:943.
-
(2007)
Am Heart J
, vol.154
, pp. 943
-
-
Saha, S.A.1
Kizhakepunnur, L.G.2
Bahekar, A.3
Arora, R.R.4
-
191
-
-
0026710526
-
Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study
-
Koskinen P, Manttari M, Manninen V, et al. Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study. Diabetes Care 1992, 15:820.
-
(1992)
Diabetes Care
, vol.15
, pp. 820
-
-
Koskinen, P.1
Manttari, M.2
Manninen, V.3
-
192
-
-
77951704587
-
Effects of combination lipid therapy in type 2 diabetes mellitus
-
[Epub ahead of print.]
-
The ACCORD Study Group Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med 2010 Mar 18, [Epub ahead of print.].
-
(2010)
N Engl J Med
-
-
-
193
-
-
0028000749
-
The long-term effects of the lipid-lowering agent fenofibrate in hyperlipidemic heart transplant recipients
-
Boissonnat P, Salen P, Guidollet J, et al. The long-term effects of the lipid-lowering agent fenofibrate in hyperlipidemic heart transplant recipients. Transplantation 1994, 58:245.
-
(1994)
Transplantation
, vol.58
, pp. 245
-
-
Boissonnat, P.1
Salen, P.2
Guidollet, J.3
-
194
-
-
0023001772
-
Fifteen-year mortality in coronary drug project patients: Long-term benefit with niacin
-
Canner PL, Berrge KG, Wenger NK, et al. Fifteen-year mortality in coronary drug project patients: long-term benefit with niacin. J Am Coll Cardiol 1986, 8:1245.
-
(1986)
J Am Coll Cardiol
, vol.8
, pp. 1245
-
-
Canner, P.L.1
Berrge, K.G.2
Wenger, N.K.3
-
195
-
-
0034644442
-
Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease. The ADMIT study: A randomized trial
-
Elam MB, Hunninghake DB, Davis KB, et al. Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease. The ADMIT study: a randomized trial. JAMA 2000, 284:1263.
-
(2000)
JAMA
, vol.284
, pp. 1263
-
-
Elam, M.B.1
Hunninghake, D.B.2
Davis, K.B.3
-
196
-
-
0037158150
-
Diabetes Multicenter Research Group: Efficacy, safety and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: Results of the Assessment of Diabetes Control and Evaluation of the Efficacy of Niaspan Trial
-
Grundy SM, Vega GL, McGovern ME, et al. Diabetes Multicenter Research Group: Efficacy, safety and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the Assessment of Diabetes Control and Evaluation of the Efficacy of Niaspan Trial. Arch Intern Med 2002, 162:1568.
-
(2002)
Arch Intern Med
, vol.162
, pp. 1568
-
-
Grundy, S.M.1
Vega, G.L.2
McGovern, M.E.3
-
197
-
-
0025183769
-
Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apoB
-
Brown G, Albers JJ, Fisher LD, et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apoB. N Engl J Med 1990, 323:1289.
-
(1990)
N Engl J Med
, vol.323
, pp. 1289
-
-
Brown, G.1
Albers, J.J.2
Fisher, L.D.3
-
198
-
-
0035969564
-
Simvastatin and niacin, antioxidant vitamins or the combination for the prevention of coronary disease
-
Brown BG, Zhao XQ, Chait A, et al. Simvastatin and niacin, antioxidant vitamins or the combination for the prevention of coronary disease. N Engl J Med 2001, 345:1583.
-
(2001)
N Engl J Med
, vol.345
, pp. 1583
-
-
Brown, B.G.1
Zhao, X.Q.2
Chait, A.3
-
199
-
-
0001194748
-
Very intensive therapy with lovastatin, niacin, and colestipol for prevention of death and myocardial infarction: A 10-year Familial Atherosclerosis Treatment Study (FATS) follow-up
-
Brown BG, Brockenbrough A, Zhao XQ, et al. Very intensive therapy with lovastatin, niacin, and colestipol for prevention of death and myocardial infarction: a 10-year Familial Atherosclerosis Treatment Study (FATS) follow-up. Circulation 1998, 98(Suppl I):I635.
-
(1998)
Circulation
, vol.98
, pp. I635
-
-
Brown, B.G.1
Brockenbrough, A.2
Zhao, X.Q.3
-
200
-
-
0030046580
-
Progression of coronary artery disease predicters clinical coronary events: Long-term follow-up from the Cholesterol Lowering Atherosclerosis Study
-
Azen SP, Mack WJ, Cashin-Hemphill L, et al. Progression of coronary artery disease predicters clinical coronary events: long-term follow-up from the Cholesterol Lowering Atherosclerosis Study. Circulation 1996, 93:34-41.
-
(1996)
Circulation
, vol.93
, pp. 34-41
-
-
Azen, S.P.1
Mack, W.J.2
Cashin-Hemphill, L.3
-
202
-
-
0034708959
-
Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol. Niaspan-Gemfibrozil Study Group
-
Guyton JR, Blazing MA, Hagar J, et al. Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol. Niaspan-Gemfibrozil Study Group. Arch Intern Med 2000, 160:1177.
-
(2000)
Arch Intern Med
, vol.160
, pp. 1177
-
-
Guyton, J.R.1
Blazing, M.A.2
Hagar, J.3
-
203
-
-
0024466520
-
Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid
-
Carlson LA, Hamsten A, Asplund A Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid. J Intern Med 1989, 226:271.
-
(1989)
J Intern Med
, vol.226
, pp. 271
-
-
Carlson, L.A.1
Hamsten, A.2
Asplund, A.3
-
204
-
-
0032539907
-
Effect of postmenopausal hormone therapy on lipoprotein(a) concentration. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions
-
Espeland MA, Marcovina SM, Miller V, et al. Effect of postmenopausal hormone therapy on lipoprotein(a) concentration. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions. Circulation 1998, 97:979.
-
(1998)
Circulation
, vol.97
, pp. 979
-
-
Espeland, M.A.1
Marcovina, S.M.2
Miller, V.3
-
205
-
-
4444266039
-
Alternative hormone replacement regimens: Is there a need for further clinical trials?
-
Welty FK Alternative hormone replacement regimens: is there a need for further clinical trials?. Curr Opin Lipidol 2003, 14:585.
-
(2003)
Curr Opin Lipidol
, vol.14
, pp. 585
-
-
Welty, F.K.1
-
206
-
-
0021278243
-
Suppression by diets rich in fish oil of very low density lipoprotein production in man
-
Nestel P, Connor WE, Reardon MF, et al. Suppression by diets rich in fish oil of very low density lipoprotein production in man. J Clin Invest 1984, 74:72.
-
(1984)
J Clin Invest
, vol.74
, pp. 72
-
-
Nestel, P.1
Connor, W.E.2
Reardon, M.F.3
-
207
-
-
0025150912
-
Effects of fish oil on VLDL triglyceride kinetics in humans
-
Harris WS, Connor WE, Illingworth DR, et al. Effects of fish oil on VLDL triglyceride kinetics in humans. J Lipid Res 1990, 31:1549.
-
(1990)
J Lipid Res
, vol.31
, pp. 1549
-
-
Harris, W.S.1
Connor, W.E.2
Illingworth, D.R.3
-
208
-
-
0034762548
-
An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia
-
Durrington PN, Bhatnagar D, Mackness MI, et al. An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia. Heart 2001, 85:544.
-
(2001)
Heart
, vol.85
, pp. 544
-
-
Durrington, P.N.1
Bhatnagar, D.2
Mackness, M.I.3
-
209
-
-
33747129222
-
Combination therapy with statins and omega-3 fatty acids
-
Nambi V, Ballantyne CM Combination therapy with statins and omega-3 fatty acids. Am J Cardiol 2006, 98:34I.
-
(2006)
Am J Cardiol
, vol.98
, pp. 34I
-
-
Nambi, V.1
Ballantyne, C.M.2
-
210
-
-
0345109256
-
Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial
-
Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999, 354:447.
-
(1999)
Lancet
, vol.354
, pp. 447
-
-
-
211
-
-
33846180976
-
Omega-3 fatty acids and prevention of arrhythmias
-
Leaf A Omega-3 fatty acids and prevention of arrhythmias. Curr Opin Lipidol 2007, 18:31.
-
(2007)
Curr Opin Lipidol
, vol.18
, pp. 31
-
-
Leaf, A.1
-
212
-
-
33947583493
-
Effects of eicosapentaenoic acid on major coronary events in hypercholesterolemic patients (JELIS): A randomized open-label, blinded endpoint analysis
-
Yokoyama M, Origasa H, Matsuzaki M, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolemic patients (JELIS): a randomized open-label, blinded endpoint analysis. Lancet 2007, 369:1090.
-
(2007)
Lancet
, vol.369
, pp. 1090
-
-
Yokoyama, M.1
Origasa, H.2
Matsuzaki, M.3
-
213
-
-
53049110571
-
Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): A randomized, double-blind, placebo-controlled trial
-
GISSI-HF Investigators Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomized, double-blind, placebo-controlled trial. Lancet 2008, 372:1223.
-
(2008)
Lancet
, vol.372
, pp. 1223
-
-
-
214
-
-
34548319692
-
Combination of Prescription Omega-3 with Simvastatin (COMBOS) Investigators: An 8-week, randomized, double-blind, placebo-controlled study of the efficacy and safety of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic subjects
-
Davidson M, Stein E, Bays H, et al. Combination of Prescription Omega-3 with Simvastatin (COMBOS) Investigators: An 8-week, randomized, double-blind, placebo-controlled study of the efficacy and safety of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic subjects. Clin Ther 2007, 29:1354.
-
(2007)
Clin Ther
, vol.29
, pp. 1354
-
-
Davidson, M.1
Stein, E.2
Bays, H.3
-
215
-
-
85134224321
-
-
Available at, Accessed June 12, 2008
-
Clinical Trial Service Unit & Epidemiological Studies Unit HPS2-THRIVE press release Available at, Accessed June 12, 2008. http://www.ctsu.ox.ac.uk/pressreleases/2006-05-31/hps2-thrive-press-release.
-
HPS2-THRIVE press release
-
-
|